Mark L. Pacala, Director: Starling Oncology STLN Sell · Filed 25/11/20

Trade details

Type: Insider sale
Amount: $186,520
Shares · price: 46,630 sh · $4.00 a share
Held after: 174,971 sh
Stock: Starling Oncology STLN
Person: Mark L. PacalaDirector
Trade date: 25/11/18
Filed: 25/11/20
Days to filing: 2 days

Sold 21.0% of holdings

Share of holding sold: 21.0%

Starling Oncology trades, last 26 weeks

What else happened in Starling Oncology around then

Filed or reported within 30 days of the trade day · 25/10/19~25/12/18

Mark L. Pacala's recent trades

Mark L. PacalaDirector
SellStarling Oncology
Sell
Starling Oncology
STLN
$4,840
1,210 sh
$4,840
Filed 25/11/20
Traded 25/11/18
Mark L. PacalaDirector
SellStarling Oncology
Sell
Starling Oncology
STLN
$8,640
2,160 sh
$8,640
Filed 25/11/20
Traded 25/11/18
Mark L. PacalaDirector
Planned saleStarling Oncology
Planned sale
Starling Oncology
STLN
$200K
50,000 sh
$200K
Filed 25/11/18
Traded 25/11/18
Mark L. PacalaDirector
BuyStarling Oncology
Buy
Starling Oncology
STLN
$94.2K
90,562 sh
$94.2K
Filed 25/03/28
Traded 25/03/26